TScan Therapeutics, Inc. (TCRX)
1.015
-0.06
(-5.14%)
USD |
NASDAQ |
Dec 12, 16:00
1.015
0.00 (0.00%)
After-Hours: 16:14
TScan Therapeutics Total Assets (Quarterly): 262.22M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 4.852B |
| Geron Corp. | 567.38M |
| Novavax, Inc. | 1.180B |
| XOMA Royalty Corp. | 263.15M |
| SELLAS Life Sciences Group, Inc. | 51.56M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 118.20M |
| Shareholders Equity (Quarterly) | 144.02M |
| Debt to Equity Ratio | 0.6639 |
| Current Ratio | 6.442 |
| Net Debt Paydown Yield | -0.88% |